Mark Peplow's Critical point

  • CW1014_Criticalpoint_300tb

    Good advice

    25 September 2014

    Rather than axing his chief scientific adviser, the next president of the European commission should enhance the role

  • CW0914_CriticalPoint_630m

    The trouble with boycotts

    29 August 2014

    Cutting academic ties with a censured state can do more harm than good, says Mark Peplow

  • CW0814_Criticalpoint_630m

    The creative stimulus

    22 July 2014

    Innovative thinking may be difficult to turn on at will, but there are many ways to prepare for inspiration, says Mark Peplow

  • CW0714_CriticalPoint_630m

    A mind-blowing legacy

    11 June 2014

    Alexander Shulgin’s research on psychoactive drugs shows how molecules can take on a life of their own once they leave the lab, says Mark Peplow


    It's life, but not as we know it

    15 May 2014

    A living cell that uses artificial bases in its DNA heralds a profound development for chemistry, says Mark Peplow


    Frack and blue

    25 April 2014

    Shale gas will do little to improve the competitiveness of Europe’s chemical industry, argues Mark Peplow

  • Beijing smog

    A war on smog

    28 March 2014

    Chemistry can be a force for good in tackling China’s pollution, says Mark Peplow

  • 0314CW-Critical-Point_300m

    The value of trust

    7 March 2014

    Rebuilding a damaged relationship with researchers should be a top priority for the new boss of the UK’s physical sciences funding council

  • 0214CW-Critical-Point_300m

    Virtually excellent

    30 January 2014

    Assembling a dream team of international researchers could offer a useful snapshot of the UK’s strength in chemical engineering, says Mark Peplow

  • 0114CW-Critical-Point_300m

    The morning after the night before

    6 January 2014

    Replacing alcohol with a more benign drug sounds like a great idea, but it faces insurmountable hurdles, says Mark Peplow